Bulat Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-07-2024
- Paid Up Capital ₹ 5.00 M
as on 17-07-2024
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Revenue 31908.12%
(FY 2019)
- Profit 226.94%
(FY 2019)
- Ebitda 246.20%
(FY 2019)
- Net Worth 29.82%
(FY 2019)
- Total Assets 309.56%
(FY 2019)
About Bulat Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Yu Zhang and Li Qiang serve as directors at the Company.
- CIN/LLPIN
U24304DL2017FTC322559
- Company No.
322559
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
23 Aug 2017
- Date of AGM
09 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bulat Pharmaceutical Private Limited offer?
Bulat Pharmaceutical Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, HIV Drugs, Insecticides and Pesticides, Termiticide, Organic and Inorganic Solvents, Chlorinated Solvents, Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Bulat Pharmaceutical?
Financial Performance and Corporate Structure Insights of Bulat Pharmaceutical.
Bulat Pharmaceutical Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 31908.12% increase. The company also saw a substantial improvement in profitability, with a 226.94% increase in profit. The company's net worth Soared by an impressive increase of 29.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bulat Pharmaceutical?
In 2019, Bulat Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bulat Pharmaceutical?
Unlock and access historical data on people associated with Bulat Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bulat Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bulat Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
